1. Home
  2. KALV vs OBT Comparison

KALV vs OBT Comparison

Compare KALV & OBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALV
  • OBT
  • Stock Information
  • Founded
  • KALV N/A
  • OBT 1892
  • Country
  • KALV United States
  • OBT United States
  • Employees
  • KALV N/A
  • OBT N/A
  • Industry
  • KALV Biotechnology: Pharmaceutical Preparations
  • OBT Major Banks
  • Sector
  • KALV Health Care
  • OBT Finance
  • Exchange
  • KALV Nasdaq
  • OBT Nasdaq
  • Market Cap
  • KALV 362.2M
  • OBT 315.3M
  • IPO Year
  • KALV N/A
  • OBT N/A
  • Fundamental
  • Price
  • KALV $8.75
  • OBT $26.72
  • Analyst Decision
  • KALV Strong Buy
  • OBT Buy
  • Analyst Count
  • KALV 7
  • OBT 1
  • Target Price
  • KALV $27.00
  • OBT $71.00
  • AVG Volume (30 Days)
  • KALV 319.9K
  • OBT 39.2K
  • Earning Date
  • KALV 03-10-2025
  • OBT 01-29-2025
  • Dividend Yield
  • KALV N/A
  • OBT 2.58%
  • EPS Growth
  • KALV N/A
  • OBT N/A
  • EPS
  • KALV N/A
  • OBT 2.56
  • Revenue
  • KALV N/A
  • OBT $98,024,000.00
  • Revenue This Year
  • KALV N/A
  • OBT N/A
  • Revenue Next Year
  • KALV N/A
  • OBT $4.83
  • P/E Ratio
  • KALV N/A
  • OBT $10.45
  • Revenue Growth
  • KALV N/A
  • OBT 4.93
  • 52 Week Low
  • KALV $7.30
  • OBT $20.50
  • 52 Week High
  • KALV $16.88
  • OBT $33.06
  • Technical
  • Relative Strength Index (RSI)
  • KALV 51.87
  • OBT 43.55
  • Support Level
  • KALV $7.30
  • OBT $25.51
  • Resistance Level
  • KALV $9.16
  • OBT $28.60
  • Average True Range (ATR)
  • KALV 0.41
  • OBT 1.08
  • MACD
  • KALV 0.07
  • OBT 0.04
  • Stochastic Oscillator
  • KALV 78.17
  • OBT 52.10

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

Share on Social Networks: